Akso Health cash flow statement data for the quarter ended Mar 2026. This cash flow statement covers 25 quarters of results from Sep 2016 through Mar 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Sep2016 | Dec2016 | Mar2017 | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Mar2020 | Mar2021 | Sep2021 | Mar2022 | Sep2022 | Mar2023 | Sep2023 | Mar2024 | Sep2024 | Mar2025 | Sep2025 | Mar2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||||||||||||
| Net Income | 26.91M | 17.05M | 29.68M | -17.40M | -9.59M | 2.85M | -7.16M | -10.40M | |||||||||||||||||
| Share-based CompensationStock Comp. | 0.08M | 4.32M | 0.83M | 0.59M | 0.59M | ||||||||||||||||||||
| Financing Activities | |||||||||||||||||||||||||
| Change in Capital Stock | |||||||||||||||||||||||||
| Net Shares Issued and RepurchasedNet Shares Issued | 0.13M | 0.62M | 0.00M | 3.49M | 0.73M | 0.59M | |||||||||||||||||||
| Additional items | |||||||||||||||||||||||||
| Beginning Cash Balance | 19.23M | 132.62M | 57.37M | 10.93M | 15.13M | 15.13M | 21.93M | 21.93M | 7.92M | 9.19M | 85.17M | 86.20M | 176.23M | 176.23M |